Ocuphire Pharma, Inc. (OCUP) Misses Q2 EPS by 1c, beats revenue

Ocuphire Pharma, Inc. (NASDAQ: OCUP) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $3.67 million versus the consensus estimate of $2.43 million.

For earnings history and earnings-related data on Ocuphire Pharma, Inc. (OCUP) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)